ETFdb Logo
  • ETF Database
  • Content Hubs
    • Themes
      • Active ETF
      • Alternatives
      • Artificial Intelligence
      • China Insights
      • Core Strategies
      • Crypto
      • Disruptive Technology
      • Energy Infrastructure
      • ETF Building Blocks
      • ETF Investing
      • ETF Strategist
      • Financial Literacy
      • Fixed Income
      • Free Cash Flow
      • Future ETFs
      • Innovative ETFs
      • Institutional Income Strategies
      • Leveraged & Inverse
      • Market Insights
      • Market Outlooks
      • Modern Alpha
      • Nuclear Energy
      • Portfolio Strategies
      • Sector Investing
      • Tax Efficient Income
      • Thematic Investing
    • Asset Class
      • Equity
        • U.S. Equity
        • Int'l Developed
        • Emerging Market Equities
      • Alternatives
        • Gold/Silver/Critical Materials
        • Cryptocurrency
        • Currency
        • Volatility
      • Fixed Income
        • Investment Grade Corporates
        • US Treasuries & TIPS
        • High Yield Corporates
        • Int'l Fixed Income
    • ETF Ecosystem
    • ETFs in Canada
    • Market Outlook
    • Crypto ETF Hub
  • Tools
    • ETF Screener
    • ETF Country Exposure Tool
    • ETF Database Categories
    • Indexes
    • Scenario Analysis
    • Watchlists
    • Head-To-Head ETF Comparison Tool
    • Mutual Fund To ETF Converter
    • ETF Stock Exposure Tool
    • ETF Issuer Fund Flows
  • Research
    • ETF Education
    • Equity Investing
    • Dividend ETFs
    • Leveraged ETFs
    • Inverse ETFs
    • Index Education
    • Index Insights
    • Top ETF Sectors
    • Top ETF Issuers
    • Top ETF Industries
  • Webcasts
  • Sectors
    • Sector Investing Content Hub
    • XLK
    • XLI
    • XLU
    • XLY
    • XLP
    • XLRE
    • Sector Power Rankings
    • XLE
    • XLC
    • XLF
    • XLV
    • XLB
  • Multimedia
    • ETF 360 Video Series
    • ETF of the Week Podcast
    • Gaining Perspective Podcast
    • ETF Prime Podcast
    • Video
  • Company
    • About VettaFi
    • Get VettaFi’ed
  • PRO
    • Pro Content
    • Pro Tools
    • Advanced
    • FAQ
    • Free sign up
    • Login
  1. ETF Building Blocks Content Hub
  2. BFOR Outperformance Expected to Continue
ETF Building Blocks Content Hub
Share

BFOR Outperformance Expected to Continue

Elle Caruso FitzgeraldJul 22, 2022
2022-07-22

The ALPS Barron’s 400 ETF (BFOR B) outperformed broader equity markets last week, as measured by the Russell 3000 Index, due to its higher quality growth-at-a-reasonable-price (GARP) fundamentals across its all-cap portfolio.

As earnings season begins, BFOR is substantially overweight to pro-cyclical sectors, including energy, industrials, financials, and materials (23.29% overweight as of July 15), where earnings are expected to be resilient to inflationary trends and higher interest rates, according to a recent insight from ALPS

While multiple compression on future earnings has dented high-priced growth stocks so far in 2022 due to rising interest rates, BFOR is outperforming the Russell 3000 Growth Index by over 500 bps year-to-date due to its higher-quality growth selection process, according to ALPS.

“Despite the current recessionary fears, a reprieve in the strength of the US dollar and potential peak inflation with energy and commodity prices declining could act as catalysts for growth stocks to perform better, as was the case last week,” ALPS wrote. “Certainly, growth investors will be a little more discerning on valuations and quality should the growth stock rotation persist, which would extend the runway for BFOR to shine.”

BFOR’s largest portfolio gainer last week was healthcare staffing provider Cross Country Healthcare Inc. (CCRN, 0.35% weight as of July 15), which rose over 16% on earnings strength from a large healthcare insurer that cited increasing non-COVID patient procedures, ALPS wrote. 

Catalyst Pharmaceuticals Inc. (CPRX, 0.32% weight as of July 15) also jumped over 13% last week after winning litigation over patent infringement and receiving exclusive rights to develop its drug, Ruzurgi, which treats muscle atrophy associated with Lambert-Eaton syndrome, according to ALPS.

Other ETFs tracking all-cap equities include the Dimensional US Core Equity Market ETF (DFAU ), the SPDR S&P Dividend ETF (SDY A), and the iShares Russell Mid-Cap Growth ETF (IWP A-).

For more news, information, and strategy, visit the ETF Building Blocks Channel.

Loading Articles...

Advertisement

Is Your Portfolio Positioned With Enough Global Exposure?

ETF Education Channel

How to Allocate Commodities in Portfolios

Tom LydonApr 26, 2022
2022-04-26

A long-running debate in asset allocation circles is how much of a portfolio an investor should...

Core Strategies Channel

Why ETFs Experience Limit Up/Down Protections

Karrie GordonMay 13, 2022
2022-05-13

In a digital age where information moves in milliseconds and millions of participants can transact...

}
X